| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/02/1998 | CA2275394A1 Antidiabetic agents |
| 07/02/1998 | CA2275312A1 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 07/02/1998 | CA2275183A1 Ob fusion protein compositions and methods |
| 07/02/1998 | CA2274799A1 Anti-obesity proteins |
| 07/01/1998 | EP0850240A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | EP0822758A4 Supplement for baby infant formula and a method of delivering that supplement |
| 07/01/1998 | CN1186518A Human vascular endothelial growth factor 2 |
| 07/01/1998 | CN1186495A Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | CN1186489A N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same |
| 07/01/1998 | CN1186074A New imidazoline compounds, process for preparing them and pharmaceutical compositions containing them |
| 07/01/1998 | CN1185950A Oral composition containing dehydroepiandrosterone and its sodium sulfate |
| 07/01/1998 | CN1185948A Inhibitor for generation of 3-deoxyglucurone |
| 07/01/1998 | CN1038932C Stereoselective preparation of substitued piperidines |
| 07/01/1998 | CN1038931C Preparation of medicinal compositions useful as anta-gonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels |
| 06/30/1998 | US5773644 Cyclopropyl alkanoic acid derivatives |
| 06/30/1998 | US5773530 Pyrazolopyridine adenosine antagonists |
| 06/30/1998 | US5773465 Tartronic acids, their acetalic ethers and o-esters |
| 06/30/1998 | US5773463 Decalcification of brain disorders |
| 06/30/1998 | US5773448 Nervous system disorders |
| 06/30/1998 | US5773447 4-amino-2-ureidopyrimidine-5-carboxamide formed by amidation |
| 06/30/1998 | US5773432 Using certain 17-difluoromethylene-estratrienes in the treatment and prevention of premature occlusive arterial disease |
| 06/30/1998 | US5773429 Drug combination for treating calcium loss |
| 06/30/1998 | US5773426 Proteoglucan and antidiabetic drug thereof |
| 06/30/1998 | US5773414 Endothelin antagonists |
| 06/30/1998 | US5773412 Use of peptides for altering αV β3 -mediated binding |
| 06/30/1998 | US5773004 Compositions for curing diabetes mellitus, processes for the preparation of same, and usage of same |
| 06/30/1998 | CA2094084C Aqueous gel vehicles for retinoids |
| 06/30/1998 | CA2085344C Injectable pharmaceutical composition |
| 06/27/1998 | CA2225906A1 3-deoxyglucosone production inhibitor |
| 06/25/1998 | WO1998027108A2 New amide compounds and their use as nitric oxide synthase inhibitors |
| 06/25/1998 | WO1998027078A1 New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications |
| 06/25/1998 | WO1998022101A3 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| 06/25/1998 | WO1998010068A3 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals |
| 06/25/1998 | CA2275346A1 New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications |
| 06/24/1998 | EP0849361A2 Novel ligands of the neuropeptide receptor HFGAN72 |
| 06/24/1998 | EP0849276A1 Anti-obesity proteins |
| 06/24/1998 | EP0848736A1 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor |
| 06/24/1998 | EP0848705A1 Crystalline r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- (phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 06/24/1998 | EP0848704A1 Form iii crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 06/24/1998 | EP0679161B1 Thiazolidine derivatives, preparation thereof and drugs containing same |
| 06/24/1998 | CN1185742A Protein kinase c inhibitors |
| 06/24/1998 | CN1185736A Use of thiazolium compounds for preventing and preverting the formation of advanced glycosylation endproducts |
| 06/24/1998 | CN1185316A Medicinal preparation containing saccharin zinc |
| 06/24/1998 | CN1038840C Para-dinitrogen naphthalene derivative, its preparation method and medical use |
| 06/23/1998 | US5770772 4-formylamino-2,3,5-trimethyl-1-(2-methyl-2-propenyloxy) -benzene; arteriosclerosis, brain and cardiovascular disorders |
| 06/23/1998 | US5770749 Extracting creamy precipitate from pulping soap using solvent mixture of water, ketone and hydrocarbon, purifying |
| 06/23/1998 | US5770687 Comformationally constrained backbone cyclized somatostatin analogs |
| 06/23/1998 | US5770611 Indole derivatives as 5HT1 -like agonists |
| 06/23/1998 | US5770594 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
| 06/23/1998 | US5770571 Method and agents for inhibiting protein aging |
| 06/23/1998 | US5770570 Method of delivering a vasoactive intestinal polypeptide, an encapsulated vasoactive intestinal polypeptide, and a method of making the encapsulated vasoactive intestinal polypeptide |
| 06/23/1998 | US5770565 Peptides for reducing or inhibiting bone resorption |
| 06/23/1998 | US5770233 Container filled with infusion liquids and infusion preparation |
| 06/23/1998 | US5770196 Modified antibody variable domains and therapeutic uses thereof |
| 06/20/1998 | CA2217698A1 Anti-obesity proteins |
| 06/18/1998 | WO1998026067A1 Adipocyte-specific differentiation-related protein |
| 06/18/1998 | WO1998025921A1 PREPARATION OF [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-CHLORO-2-THIENYL) METHYL]PROPYL]AMINO]-3H-IMIDAZO[4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE |
| 06/18/1998 | WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 06/18/1998 | WO1998025644A1 Compositions and methods for enhancing intestinal function |
| 06/18/1998 | WO1998025628A1 Pharmaceutical compositions containing alendronate and an agent promoting gastric emptying |
| 06/18/1998 | WO1998009644A3 Method for lowering cholesterol levels |
| 06/18/1998 | WO1998005361A3 Long-acting drugs and pharmaceutical compositions comprising them |
| 06/18/1998 | CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 06/18/1998 | CA2274728A1 Adipocyte-specific differentiation-related protein |
| 06/18/1998 | CA2250221A1 Pharmaceutical compositions containing alendronate and an agent promoting gastric emptying |
| 06/17/1998 | EP0848061A2 Self-enhancing, pharmacologically controllable expression systems |
| 06/17/1998 | EP0848060A2 Novel human 11CB splice variant |
| 06/17/1998 | EP0847379A1 Phenoxy acetic acids as aldose reductase inhibitors and antihyperglycemic agents |
| 06/17/1998 | EP0847281A1 Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases |
| 06/17/1998 | EP0847278A1 Analogs of parathyroid hormone |
| 06/17/1998 | CN1184661A Chinese patent drug for treating effevctively old and feeble type disease |
| 06/17/1998 | CN1184640A Drug for curing diabetes |
| 06/16/1998 | US5767141 Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseases |
| 06/16/1998 | US5767133 Secondary amines as antidiabetic and antiobesity agents |
| 06/16/1998 | US5767123 Total parenteral nutrition solution containing water-soluble vitamin B |
| 06/16/1998 | US5767118 4-Heterocyclic peperidines promote release of growth hormone |
| 06/16/1998 | US5767115 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 06/16/1998 | US5767111 18-nor-vitamin D compounds |
| 06/16/1998 | US5767094 Hypoglycemic agents |
| 06/16/1998 | US5767085 Peptide derivatives |
| 06/16/1998 | US5767075 Inhibiting protein interactions |
| 06/16/1998 | US5767066 Medical application of bromelain |
| 06/16/1998 | US5766886 Modified antibody variable domains |
| 06/16/1998 | CA2162470C Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance |
| 06/16/1998 | CA2132831C Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans |
| 06/16/1998 | CA2003718C Compounds |
| 06/11/1998 | WO1998024922A1 Insulin-like growth factor i (igf-i) expression system and methods of use |
| 06/11/1998 | WO1998024888A2 Polypeptides encoded by a human lipase-like gene, compositions and methods |
| 06/11/1998 | WO1998024788A1 Tropane derivatives and method for their synthesis |
| 06/11/1998 | WO1998024782A2 Substituted pyrimidine compounds and their use |
| 06/11/1998 | WO1998024780A2 Substituted pyrimidinone and pyridinone compounds and their use |
| 06/11/1998 | WO1998024771A1 Benzamide derivatives having a vasopressin antagonistic activity |
| 06/11/1998 | WO1998024766A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 06/11/1998 | WO1998024762A1 Vitamin d3 derivatives |
| 06/11/1998 | WO1998024756A1 Phenyl acetamides as spla2 inhibitors |
| 06/11/1998 | WO1998024422A2 Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein |
| 06/11/1998 | CA2273995A1 Phenyl acetamides as spla2 inhibitors |
| 06/11/1998 | CA2272148A1 Vitamin d3 derivatives |
| 06/11/1998 | CA2269674A1 Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein |
| 06/11/1998 | CA2224334A1 Self-enhancing, pharmacologically controllable expression systems |